AWARDDEFINITIVE CONTRACTOther than small business
Definitive contract 75N93023C00003BARUCH S. BLUMBERG INSTITUTE
Overview
Award facts
- Net obligations
- $16.24M
- $16,240,850of $32.35M potential value
- Outlays (paid to date)
- $10.78M
- $10.78M paid of $16.24M obligated$10,778,648
- Period of performance
- Nov 15, 2022 to Nov 30, 2027
- Ends in 12 months
- Modifications
- 11
- Latest action Jul 24, 2026
- Contract type
- Definitive contract
- PIID 75N93023C00003
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
TO DEVELOP AN ORALLY AVAILABLE SMALL MOLECULE ANTIVIRAL DRUG, WITH TREATMENT OF YELLOW FEVER VIRUS INFECTION AS THE PRIMARY INDICATION.
Dates and value
- Award date
- Signed on Nov 15, 2022
- Current value
- $16,240,850Base and exercised options
- Potential value (if all options are exercised)
- $32,348,261
Obligations by fiscal year of action
- FY2026: $3,760,574
- FY2024: $6,986,400
- FY2023: $5,493,876
Total across 3 fiscal years: $16,240,850
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jul 24, 2026. View on USAspending · Recipient on SAM.gov
Recipient
LocationDOYLESTOWN, PA
UEINAYCKSJB7F68
CAGE code47W56
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate tax exempt
Parent companyBARUCH S. BLUMBERG INSTITUTE
Business types and certifications
Nonprofit organizationTax-exempt corporation
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIAID
- Funded from
- Public health and social services emergency fund; National institute of allergy and infectious diseases (0885)Program activities075-0140, 075-0885Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Doylestown, Bucks County, Pennsylvania 18902-8400
- Congressional district (place of performance)
- PA-01As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH (research and development)
Competition
- Extent competed
- Full and open competitionA
- Solicitation procedures
- Negotiated proposal/quoteNP
- Set-aside
- No set-aside used
- Contract pricing
- Cost plus fixed feeU
- Offers received
- 10
Solicitation and notices
- Solicitation ID
- BAA2022-1(as reported)
- Solicitation date
- Jan 18, 2022
Contract details
- Subcontracting plan
- Individual subcontract planF
- Cost Accounting Standards clause
- Yes - CAS clause includedY
- Certified cost or pricing data
- Yes
- Commercial procedures
- Commercial products/services procedures not usedD
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Nov 15, 2022Base obligation at award: $5,493,876
- Latest action
- Jul 24, 2026 — Other administrative actionModification P00011; administrative: no change in scope or value
- Latest substantive action
- May 14, 2026 — Option exercisedModification P00010; obligation change +$3,760,574
- Actions by type
- Base award1
- Other administrative action6
- Option exercised3
- Supplemental agreement (within scope)1
- Change order1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N930
- Transactions recorded under this award key
- 12
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N930
- Treasury accounts
- 075-2020/2024-0885-000
- 075-2024/2024-0885-000
- 075-2026/2026-0885-000
- 075-X-0140-000
- Object classes
- 25.5: Research and development contracts
- Disaster or emergency funding (DEFC)
- N: Emergency P.L. 116-136
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression
- V: Non-emergency P.L. 117-2
- COVID-19 supplemental obligations
- $9,513,876
- COVID-19 supplemental outlays
- $8,129,459